Compare CAH & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAH | ALC |
|---|---|---|
| Founded | 1979 | 1945 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.4B | 39.4B |
| IPO Year | N/A | N/A |
| Metric | CAH | ALC |
|---|---|---|
| Price | $197.97 | $78.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $200.25 | $88.71 |
| AVG Volume (30 Days) | ★ 2.3M | 1.7M |
| Earning Date | 01-29-2026 | 11-11-2025 |
| Dividend Yield | ★ 1.03% | 0.27% |
| EPS Growth | ★ 27.25 | N/A |
| EPS | ★ 6.63 | 2.10 |
| Revenue | ★ $234,310,000,000.00 | $10,185,000,000.00 |
| Revenue This Year | $16.60 | $5.79 |
| Revenue Next Year | $8.92 | $7.36 |
| P/E Ratio | ★ $29.91 | $36.85 |
| Revenue Growth | ★ 4.39 | 4.34 |
| 52 Week Low | $114.60 | $71.55 |
| 52 Week High | $214.93 | $99.20 |
| Indicator | CAH | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 49.55 | 52.90 |
| Support Level | $197.36 | $78.55 |
| Resistance Level | $202.22 | $80.39 |
| Average True Range (ATR) | 3.39 | 1.21 |
| MACD | -2.63 | -0.03 |
| Stochastic Oscillator | 2.79 | 47.42 |
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.